Analyst Ratings for Protagonist Therapeutics (PTGX)
PTGX Rating Summary
PTGX Price Target Summary
- Highest: $225.00 (Wolfe Research)
- Lowest: $73.00 (Leerink)
- Average: $159.64
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$159.64 (+9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$159.64 (+9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/10/2026 | Goldman Sachs | Richard Law | Upgrade | Buy (Neutral) |
186.00 (110.00) |
146.18 (146.49) |
0.21% | Details |
| 5/21/2026 | Wolfe Research » Updated 8/31/2026 |
Alexandria Hammond | New Coverage | Outperform (N/A) |
225.00 (N/A) |
100.88 (146.49) |
45.21% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
